Chris Fashek is an accomplished healthcare executive with a winning record of leading billion dollar global and start-up medical-device and pharmaceutical businesses.
Chris is the Chairman of the Board of MedTech Solutions Group (MTSG), a global Sales Management, Marketing and Clinical team managing a worldwide distributor network and is also the Chairman at NanoVibronix (NAOV – NASDAQ).
He currently serves as a board member for Argentum Medical, a Shore Capital Company, Hip Innovation Technology, World Craniofacial Foundation, Wound Healing Foundation and McKenna Lecture Committee (ASU).
He has played key roles in several wound care driven technologies including the CEO of Spiracur, Inc., Chairman of the Board at Systagenix and Vice Chairman, President and CEO of KCI USA.
Chris is a subject matter expert in business development, marketing, sales, product development, and positioning corporations for hyper-growth and sustainability. He holds his MBA from Fairleigh Dickinson University and Bachelor of Arts in History from Upsala College.